Literature DB >> 10089852

Has the survival of the heart failure population changed? Lessons from trials.

J G Cleland1, A Clark.   

Abstract

Heart failure is a common and growing problem with a poor prognosis both in terms of morbidity and mortality. Furthermore, the natural history of heart failure can be modified dramatically by appropriate therapy. The purposes of this article are to (1) describe briefly the epidemiology and current therapy of heart failure; (2) examine potential differences between heart failure as studied in the clinical trials, compared with heart failure in the community; and (3) suggest a number of areas where improvements might be made or further research is required.

Entities:  

Mesh:

Year:  1999        PMID: 10089852     DOI: 10.1016/s0002-9149(98)01011-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Emerging indications for permanent pacing.

Authors:  D L Wolbrette; G V Naccarelli
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

2.  Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.

Authors:  N P Nikitin; P H Loh; R de Silva; J Ghosh; O Y Khaleva; K Goode; A S Rigby; F Alamgir; A L Clark; J G F Cleland
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Effect of a medication-taking behavior feedback theory-based intervention on outcomes in patients with heart failure.

Authors:  Jia-Rong Wu; Donna J Corley; Terry A Lennie; Debra K Moser
Journal:  J Card Fail       Date:  2011-10-19       Impact factor: 5.712

4.  Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Debra K Moser; Misook L Chung; Terry A Lennie
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

5.  Consultation with cardiologists for persons with new-onset chronic heart failure: a population-based study.

Authors:  Debbie Ehrmann Feldman; Yongling Xiao; Sasha Bernatsky; Jeannie Haggerty; Karen Leffondré; Pierre Tousignant; Yves Roy; Michael Abrahamowicz
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

6.  Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.

Authors:  Debbie Ehrmann Feldman; Anique Ducharme; Marc Frenette; Nadia Giannetti; Caroline Michel; François Grondin; Richard Sheppard; Hassan Behlouli; Louise Pilote
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

7.  Predictors of medication adherence using a multidimensional adherence model in patients with heart failure.

Authors:  Jia-Rong Wu; Debra K Moser; Misook L Chung; Terry A Lennie
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

Review 8.  Devices for the management of ventricular arrhythmias in cardiac failure.

Authors:  Michael Cooklin
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 9.  Carvedilol in the treatment of elderly patients with chronic heart failure.

Authors:  Klaus K A Witte; Andrew L Clark
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.